Synthesis of platinacyclobutanes bearing biological components for targeted, cisplatin prodrugs

Organometallics

Volumn 25, Issue 19, 2006, Pages 4537-4541

  Stocker, Bridget L ^a   Hoberg, John O ^b  

^a VICTORIA UNIVERSITY OF WELLINGTON   (New Zealand)

^b UNIVERSITY OF WYOMING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMOLECULES; CISPLATIN PRODRUGS; CYCLOPROPYLMETHANOL; PLATINACYCLOBUTANES;

CHOLESTEROL; COMPLEXATION; GLUCOSE; PLATINUM; REACTION KINETICS;

ORGANOMETALLICS;

EID: 33748804926     PISSN: 02767333     EISSN: None     Source Type: Journal    
DOI: 10.1021/om060146s     Document Type: Article

References (32)

1. Wang, D.; Lippard, S. J. Nat. Rev. Drug Discuss. 2005, 4, 307.
2. Rosenberg, B.; VanCamp, L.; Trosko, J. E.; Mansour, V. H. Nature 1969, 222, 385.
3. Lippert, B. L. Cisplatin: Chemistry and Biochemistry of a Leading Anticancer Drug; Wiley-VCH: Zurich, 1999.
4. Wong, E.; Giandomenico, C. M. Chem. Rev. 1999, 99, 2451.
5. Giandomenico, C. M.; Abrams, M. J.; Murrer, B. A.; Vollano, J. F.; Rheinheimer, M. I.; Wyer, S. B.; Bossard, G. E.; Higgins, J. D. Inorg. Chem. 1995, 34, 1015.
6. Shi, T.; Berglung, J.; Elding, L. I. Inorg. Chem. 1996, 35, 3498.
7. Talman, E. G.; Bruning, W.; Reedijk, J.; Spek, A. L.; Veldman, N. Inorg. Chem. 1997, 36, 854.
8. Jennings, P. W.; Johnson, L. L. Chem. Rev. 1994, 94, 2241.
9. A number of methods including external radiation and cellular agents are being invesitagated and will be reported in due course.
10. After passive diffusion across the cellular membrane, the lower chloride concentration of the cytoplasm allows the chloride ligands of cisplatin to exchange with water. The aqua ligands may also be displaced by hydroxide ions depending on the hydrogen ion concentration. See ref 1.
11. Barinaga, M. Science 1998, 279, 323.
12. Hoberg, J. O.; Jennings, P. W. Organometallics 1992, 10, 8.
13. Burton, J. T.; Puddephatt, R. J. Organometallics 1986, 5, 1312.
14. Xu, T.; Marshall Werner, R.; Lee, K.-C.; Fettinger, J. C.; Davis, J. T.; Coward, J. K. J. Org. Chem. 1998, 63, 4767.
15. Burton, J. T.; Puddephatt, R. J.; Jones, N. L.; Ibers, J. A. Organometallics 1983, 2, 1487.
16. Peacock, G. F.; Ji, B.; Wang, C. K.; Lu, D. R. Drug Delivery 2003, 10, 29.
17. Asai, T.; Kurohane, K.; Okada, S.; Shuto, S.; Awano, H.; Matsuda, A.; Tsukada, H.; Oku, N. Drug Delivery Syst. 1999, 14, 103.
18. Ziegler, F. E.; Brown, E. G.; Sobolov, S. B. J. Org. Chem. 1990, 55, 3691.
19. Kawabata, N.; Nakagawa, T.; Nakao, T.; Yamashita, S. J. Org. Chem. 1977, 42, 3031.
20. Furukawa, J.; Kawabata, N.; Nishimura, J. Tetrahedron 1968, 24, 53.
21. Arner, E. S. J.; Eriksson, S. Pharmacol. Ther. 1995, 67, 155.
22. Furusawa, K.; Ueno, K.; Katsura, T. Chem. Lett. 1990, 97.
23. Duncan, R.; Hume, I.; Kopeckova, P.; Ulbrich, K.; Strohalm, J.; Kopecek, J. J. Controlled Release 1989, 10, 51.
24. Seymour, L. W.; Ulbrich, K.; Wedge, S. R.; Hume, I. C.; Strohalm, J.; Duncan, R. Br. J. Cancer 1991, 63, 859.
25. David, A.; Kopeckova, P.; Minko, T.; Rubinstein, A.; Kopecek, J. Eur. J. Cancer 2004, 40, 148.
26. Schmidt, R. R.; Michel, J. Angew. Chem. 1980, 92, 763.
27. Zhang, J.; J., K. Carbohydr. Chem. 1999, 18, 461.
28. Lemieux, R. U.; Koto, S. Tetrahedron 1974, 30, 1933.
29. Pinto, P. M.; Leung, R. Y. N. In ACS Symposium Series 539; Thatcher, G. R. J., Ed.; American Chemical Society: Washington, DC, 1993; p 126.
30. Shujiro, S.; Yutaka, T.; Kazuo, T.; Yohko, Y. J. Am. Chem. Soc. 1978, 100, 3331.
31. Yamada, H.; Hayashi, T. Carbohydr. Res. 2002, 337, 581.
32. Folie acid has been demonstrated to be a ligand for targeting of liposomes to ascitic tumor cells and tumor-associated macrophages in vivo: Turk, M. J.; Waters, D. J.; Low, P. S. Cancer Lett. 2004, 213, 165.